Biblio

Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is V  [Clear All Filters]
Journal Article
Anon. Volume 87A, Number 10, October 2015 Cover Image. Cytometry A. 2015;87(10).
Octavera A, Yamakawa K, Yoshizaki G. The volume and shape of bitterling eggs are more strongly influenced by germ cell autonomy than by the surrounding somatic cells. Fish Physiol Biochem. 2023.
Buehlmeyer A, Barapatre N, Schmitz C, F von Koch E, Haeussner E, Frank H-G. The volume of villi with γ-sm-actin positive perivascular cells correlates with placental weight and thickness. Placenta. 2019;85:24-31.
Bahn E, van Heerden M, Sachse KNicholas, Gueulette J, Slabbert JP, Alber M, Shaw W. Volume-dependent dose-response of the intestinal stem cell niche and lymphoid tissue. Radiother Oncol. 2020.
Morales-Curiel LFelipe, Gonzalez ACarolina, Castro-Olvera G, Lin L-CLynn, El-Quessny M, Porta-de-la-Riva M, Severino J, Morera LBattle, Venturini V, Ruprecht V, et al. Volumetric imaging of fast cellular dynamics with deep learning enhanced bioluminescence microscopy. Commun Biol. 2022;5(1):1330.
Benavides OR, Gibbs HC, White BP, Kaunas R, Gregory CA, Walsh AJ, Maitland KC. Volumetric imaging of human mesenchymal stem cells (hMSCs) for non-destructive quantification of 3D cell culture growth. PLoS One. 2023;18(3):e0282298.
Ems G, Severino L, Nisolle J-F, Nicaise C, Lambrichts I, LoMonaco M, Bronckaers A, Hontoir F, Vandeweerd J-M. Volumetry of ovine incisors dental pulp for further regenerative therapy. Anat Histol Embryol. 2023.
Pourfathollah AAkbar, Shamsasenjan K, Dehshal MHadipour. Voluntary Unpaid Plasma Donation. Int J Hematol Oncol Stem Cell Res. 2023;17(1):1-3.
Dachy G, Vankeerbergen M, Vanlangendonck N, Straetmans N, Lambert C, Hermans C, Poire X. Von Willebrand factor as a potential predictive biomarker of early complications of endothelial origin after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2024.
Leigh ND, Sessa S, Dragalzew AC, Payzin-Dogru D, Sousa JF, Aggouras AN, Johnson K, Dunlap GS, Haas BJ, Levin M, et al. von Willebrand factor D and EGF domains is an evolutionarily conserved and required feature of blastemas capable of multitissue appendage regeneration. Evol Dev. 2020.
Pagliari MTeresa, Budde U, Baronciani L, Eshghi P, Ahmadinejad M, Badiee Z, Baghaipour M-R, Hidalgo OBenítez, Biguzzi E, Bodó I, et al. von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS. J Thromb Haemost. 2023.
Pagliari MTeresa, Rosendaal FR, Ahmadinejad M, Badiee Z, Baghaipour M-R, Baronciani L, Hidalgo OBenítez, Bodó I, Budde U, Castaman G, et al. Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study. J Thromb Haemost. 2022.
Lindsay J, Krantz EM, Morris J, Sweet A, Tverdek F, Joshi A, Yeh R, Hill JA, Greenwood M, Chen SC-A, et al. Voriconazole in hematopoietic stem cell transplantation and cellular therapies: Real-world usage and therapeutic level attainment at a major transplant center. Transplant Cell Ther. 2022.
Jørgensen KJuhl, Gøtzsche PC, Dalbøge CS, Johansen HKrogh. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia. Cochrane Database Syst Rev. 2014;2:CD004707.
Bucknor MD, Gross AJ, Link TM. Voriconazole-induced periostitis in two post-transplant patients. J Radiol Case Rep. 2013;7(8):10-7.
Thekkudan SFrancis, Kumar P, Nityanand S. Voriconazole-induced skeletal fluorosis in an allogenic hematopoietic stem cell transplant recipient. Ann Hematol. 2016.
Alatrash G, Saberian C, Bassett R, Thall PF, Ledesma C, Lu Y, Daher M, Valdez BC, Kawedia J, Popat U, et al. Vorinostat combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-term Study Outcomes. Transplant Cell Ther. 2022.
Nieto Y, Valdez BC, Thall PF, Ahmed S, Jones RB, Hosing C, Popat U, Shpall EJ, Qazilbash M, Gulbis A, et al. Vorinostat Combined with High-Dose Gemcitabine, Busulfan and Melphalan with Autologous Stem-Cell Transplantation in Patients with Refractory Lymphomas. Biol Blood Marrow Transplant. 2015.
Zierfuss B, Weinhofer I, Kühl J-S, Köhler W, Bley A, Zauner K, Binder J, Martinović K, Seiser C, Hertzberg C, et al. Vorinostat in the acute neuroinflammatory form of X-linked adrenoleukodystrophy. Ann Clin Transl Neurol. 2020.
Xu S, De Veirman K, Vanderkerken K, Van Riet I. Vorinostat-induced bone loss might be related to the drug toxicity. Bone. 2013.
Awan H, Balasubramaniam S, Odysseos A. A Voxel Model to Decipher the Role of Molecular Communication in the Growth of Glioblastoma Multiforme. IEEE Trans Nanobioscience. 2021;PP.
Tutak I, Özdil B, Uysal A. Voxtalisib and low intensity pulsed ultrasound combinatorial effect on glioblastoma multiforme cancer stem cells via PI3K/AKT/mTOR. Pathol Res Pract. 2022;239:154145.
Guo W, Tsujimura K, I MOtsuka, Irie K, Igarashi K, Nakashima K, Zhao X. VPA Alleviates Neurological Deficits and Restores Gene Expression in a Mouse Model of Rett Syndrome. PLoS One. 2014;9(6):e100215.
Li Y, Cui C, Xie F, Kiełbasa S, Mei H, van Dinther M, van Dam H, Bauer A, Zhang L, Dijke PTen. VprBP mitigates TGF-β and Activin signaling by promoting Smurf1-mediated type I receptor degradation. J Mol Cell Biol. 2019.
Nicholls H. VSELs: is ideology overtaking science?. Cell Stem Cell. 2013;13(2):143-4.

Pages